Springworks Therapeutics's market cap is currently $4.27B. The company's EPS TTM is $-3.727; its P/E ratio is ―; Springworks Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 5.45M	$ 6.15M	$ 0.00	$ 35.00M	$ 0.00
Gross Profit	$ 5.03M	$ 4.25M	$ -490.00K	$ 34.65M	$ -192.00K
Operating Income	$ -343.01M	$ -280.67M	$ -173.47M	$ -46.32M	$ -59.24M
EBITDA	$ -341.35M	$ -280.67M	$ -172.98M	$ -45.98M	$ -59.05M
Net Income	$ -325.10M	$ -274.16M	$ -173.21M	$ -44.24M	$ -54.76M
Balance Sheet
Cash & Short-Term Investments	$ 479.20M	$ 597.01M	$ 373.50M	$ 508.48M	$ 327.65M
Total Assets	$ 725.79M	$ 630.24M	$ 452.49M	$ 576.19M	$ 334.83M
Total Debt	$ 7.06M	$ 5.25M	$ 1.29M	$ 2.73M	$ 0.00
Net Debt	$ -169.00M	$ -62.24M	$ -102.67M	$ -144.35M	$ -327.65M
Total Liabilities	$ 99.57M	$ 72.05M	$ 30.10M	$ 19.13M	$ 12.76M
Stockholders' Equity	$ 626.22M	$ -569.93M	$ 422.40M	$ 557.06M	$ 322.07M
Cash Flow
Free Cash Flow	$ -230.18M	$ -171.76M	$ -129.89M	$ -32.83M	$ -48.11M
Operating Cash Flow	$ -222.79M	$ -161.56M	$ -127.88M	$ -32.19M	$ -47.44M
Investing Cash Flow	$ 34.75M	$ -215.60M	$ 83.59M	$ -418.83M	$ -4.26M
Financing Cash Flow	$ 296.64M	$ 340.70M	$ 1.16M	$ 270.49M	$ 333.71M

Currency in USD

Springworks Therapeutics Earnings and Revenue History

Income Statement >

Springworks Therapeutics Debt to Assets

Balance Sheet >

Springworks Therapeutics Cash Flow

Cash Flow >

Springworks Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing